Novogen Research Pty Limited

George Eustace Joannou

Graham Edmund Kelly

Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (1), in which Z is H, Ris H, or RCO where Ris Calkyl or an amino acid, Ris H, OH, or ORwhere Ris an amino acid, or CORwhere Ris as previously defined, W is H, A is H or OH, and B is selected from (a), (b), (c), or W is H, and A and B taken together form a six-membered ring selected from (d), or W, A and B taken with the groups with which they are associated comprise (e), or W and A taken together with the groups with which they are associated comprise (f) and B is (g) wherein Ris H, CORwhere Ris as previously defined, CORwhere Ris Calkyl, or CORwhere Ris as previously defined, Ris H, CORwhere Ris H, OH, Calkyl or an amino acid, CORwhere Ris as previously defined, CORwhere Ris H, Calkyl or an amino acid, COOH, CORwhere Ris as previously defined, or CONHRwhere Ris as previously defined, Ris H, CORwhere Ris as previously defined, or CORORwhere Rand Rare as previously defined, and where the two Rgroups are attached to the same group they are the same or different, Ris H or hydroxy Calkyl, X is preferably O, but may be N or S, and Y is (h) where Ris H, or Calkyl. 

Therapeutic methods and compositions involving isoflavones

Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (I), in which Z is H, Ris H, or RCO where Ris Calkyl or an amino acid, Ris H, OH, or ORwhere Ris an amino acid, or CORwhere Ris as previously defined, W is H, A is H or OH, and B is selected from (a), (b), (c), or W is H, and A and B taken together form a six-membered ring selected from (d), or W, A and B taken with the groups with which they are associated comprise (e), or W and A taken together with the groups with which they are associated comprise (f) and B is (g) wherein Ris H, CORwhere Ris as previously defined, CORwhere Ris Calkyl, or CORwhere Ris as previously defined, Ris H, CORwhere Ris H, OH, Calkyl or an amino acid, CORwhere Ris as previously defined, CORwhere Ris H. Calkyl or an amino acid, COOH, CORwhere Ris as previously defined, or CONHRwhere Ris as previously defined, Ris H, CORwhere Ris as previously defined, or CORORwhere Rand Rare as previously defined, and where the two Rgroups are attached to the same group they are the same or different, Ris H or hydroxy Calkyl, X is preferably O, but may be N or S, and Y is (h) where Ris H, or Calkyl. 

Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (1), in which Z is H, Ris H, or RCO where Ris Calkyl or an amino acid, Ris H, OH, or ORwhere Ris an amino acid, or CORA where Ris as previously defined, W is H, A is H or OH, and B is selected from (a), (b), (c), or W is H, and A and B taken together form a six-membered ring selected from (d), or W, A and B taken with the groups with which they are associated comprise (e), or W and A taken together with the groups with which they are associated comprise (f) and B is (g) wherein Ris H, CORwhere Ris as previously defined, CORwhere Ris Calkyl, or CORwhere Ris as previously defined, Ris H, CORwhere Ris H, OH, Calkyl or an amino acid, CORwhere Ris as previously defined, CORwhere Ris H, Calkyl or an amino acid, COOH, CORwhere Ris as previously defined, or CONHRwhere Ris as previously defined, Ris H, CORwhere Ris as previously defined, or CORORwhere Rand Rare as previously defined, and where the two Rgroups are attached to the same group they are the same or different, Ris H or hydroxy Calkyl, X is preferably O, but may be N or S, and Y is (h) where Ris H, or Calkyl 

Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (I), in which Z is H, R is H, or R CO where R is C alkyl or an amino acid, R is H, OH, or OR where R is an amino acid, or COR where R is as previously defined, W is H, A is H or OH, and B is selected from (a), (b), (c), or W is H, and A and B taken together form a six-membered ring selected from (d), or W, A and B taken with the groups with which they are associated comprise (e), or W and A taken together with the groups with which they are associated comprise (f) and B is (g) wherein R is H, COR where R is as previously defined, CO R where R is C alkyl, or COR where R is as previously defined, R is H, COR where R is H, OH, C alkyl or an amino acid, CO R where R is as previously defined, COR where R is H, C alkyl or an amino acid, COOH, COR where R is as previously defined, or CONHR where R is as previously defined, R is H, CO R where R is as previously defined, or COR OR where R and R are as previously defined, and where the two R groups are attached to the same group they are the same or different, R is H or hydroxy C alkyl, X is preferably O, but may be N or S, and Y is (h) where R is H, or C alkyl.

Growing community of inventors

New South Wales, Australia

George Eustace Joannou